How To Use HCPCS Code C9466

HCPCS code C9466 describes the injection of benralizumab, with a dosage of 1 mg. This code is used to identify and bill for this specific medical procedure. In this article, we will explore the details of HCPCS code C9466, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS C9466?

HCPCS code C9466 is a specific code used to identify the injection of benralizumab, with a dosage of 1 mg. It is important for medical coders to accurately assign this code when billing for this particular procedure.

2. Official Description

The official description of HCPCS code C9466 is “Injection, benralizumab, 1 mg”. The short description for this code is “Parenteral supp not othrws c”. It is essential to use the exact official description and short description when assigning this code.

3. Procedure

1. The provider prepares the necessary equipment and medication for the injection of benralizumab.
2. The patient’s medical history and any allergies are reviewed to ensure the safety of the procedure.
3. The provider cleans the injection site with an antiseptic solution.
4. The provider administers the injection of benralizumab, ensuring proper dosage and technique.
5. After the injection, the provider disposes of any used needles or syringes in a safe manner.
6. The patient may be monitored for a period of time following the injection to observe for any adverse reactions.

4. When to use HCPCS code C9466

HCPCS code C9466 should be used when billing for the injection of benralizumab, with a dosage of 1 mg. It is important to ensure that the procedure performed matches the description provided by this code. Medical coders should review the patient’s medical records and documentation to confirm the use of this code.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C9466, healthcare providers should ensure that the following documentation is included:

• Medical records supporting the need for the injection of benralizumab
• Date and time of the procedure
• Documentation of the dosage administered
• Any relevant patient information, such as allergies or previous adverse reactions

6. Historical Information and Code Maintenance

HCPCS code C9466 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. This code has a termination date of December 31, 2018. No maintenance actions have been taken for this code, as indicated by the action code N, which means no maintenance for this code.

7. Medicare and Insurance Coverage

HCPCS code C9466 may have specific coverage instructions that apply, as indicated by the coverage code D. The pricing indicator code for this code is 57, which means it is priced by other carriers. The multiple pricing indicator code is A, indicating that it is not applicable as HCPCS priced under one methodology. Healthcare providers should review the specific coverage and pricing guidelines provided by Medicare or other insurance carriers to determine the reimbursement for this procedure.

8. Examples

Here are five examples of when HCPCS code C9466 should be billed:

1. A patient with severe asthma receives an injection of benralizumab, 1 mg, as part of their treatment plan.
2. A healthcare provider administers an injection of benralizumab, 1 mg, to a patient with eosinophilic granulomatosis with polyangiitis.
3. A patient with chronic obstructive pulmonary disease (COPD) receives an injection of benralizumab, 1 mg, to help manage their symptoms.
4. A healthcare provider administers an injection of benralizumab, 1 mg, to a patient with severe allergic asthma.
5. A patient with moderate to severe atopic dermatitis receives an injection of benralizumab, 1 mg, to help control their symptoms.